These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14692119)

  • 21. Hyperlipidemia and cardiovascular disease: should we abandon HDL cholesterol as a therapeutic target in coronary heart disease.
    Nofer JR
    Curr Opin Lipidol; 2010 Aug; 21(4):392-3. PubMed ID: 20625261
    [No Abstract]   [Full Text] [Related]  

  • 22. [The antioxidant probucol as a regulator of the intensity of free-radical lipid peroxidation processes in the blood of patients with coronary atherosclerosis].
    Tikhaze AK; Lankin VZ; Mikhin VP; Revenko VM; Lupanov VP
    Ter Arkh; 1997; 69(9):35-41. PubMed ID: 9411823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of hormone replacement therapy on hyperlipidemia].
    Honjo H; Tanaka K
    Nihon Rinsho; 1999 Dec; 57(12):2848-53. PubMed ID: 10638224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The art of modeling adherence: shades or shapes?
    Parienti JJ
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1114-6. PubMed ID: 26183118
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-oxidant therapy for ischaemic heart disease: where do we stand?
    Stephens N
    Lancet; 1997 Jun; 349(9067):1710-1. PubMed ID: 9193375
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lipids and primary prevention of coronary disease].
    Idzior-Waluś B
    Przegl Lek; 1998; 55(2):77-84. PubMed ID: 9695648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events.
    de Raucourt E; Roussel-Robert V; Zetterberg E
    Eur J Haematol; 2015 Feb; 94 Suppl 77():23-9. PubMed ID: 25560791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale for aggressive lipid lowering in high-risk patients.
    Cohen JD
    J Am Osteopath Assoc; 2011 Apr; 111(4 Suppl 3):eS7-12. PubMed ID: 21593473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention].
    Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895
    [No Abstract]   [Full Text] [Related]  

  • 30. [The clinical pharmacology and efficacy of statins].
    Sidorenko BA; Preobrazhenskiĭ DV; Sopoleva IuV
    Ter Arkh; 1996; 68(9):80-4. PubMed ID: 9005624
    [No Abstract]   [Full Text] [Related]  

  • 31. [Metabolic origins of myocardial ischemia].
    PLETSCHER A
    Cardiologia (Basel); 1962; 40():97-112. PubMed ID: 14487200
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in the blood content of some vitamins in patients with ischemic heart disease].
    Boev SS
    Lik Sprava; 2003; (5-6):26-7. PubMed ID: 14618796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins: established indications and controversial subgroups.
    Goldstein MR; Mascitelli L; Pezzetta F
    Heart; 2009 May; 95(10):846-7. PubMed ID: 19401284
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hyperlipidemia and primary prevention of ischemic heart disease].
    Gérvas J; Pérez Fernández M
    Med Clin (Barc); 1997 Oct; 109(14):549-52. PubMed ID: 9508617
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathobiology of coronary ischemic events: clinical implications.
    Gallo R; Badimon JJ; Fuster V
    Adv Intern Med; 1998; 43():203-32. PubMed ID: 9506183
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of long-term Enduracin monotherapy on the clinical and biochemical status of patients with ischemic heart disease].
    Kukharchuk VV; Solov'ev EIu; Malyshev PP; Rozhkova TA; Semenova OA; Aronskaia EE
    Ter Arkh; 1997; 69(9):41-5. PubMed ID: 9411824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimal medical therapy in diabetic patients with coronary artery disease].
    Ogita M; Daida H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():311-8. PubMed ID: 27266109
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lipid reduction without medication. What effect does diet have on lipids?].
    Vogt A; Steinhagen-Thiessen E
    Pharm Unserer Zeit; 2003; 32(6):452-7. PubMed ID: 14639825
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of tongxinluo capsule on experimental myocardial ischemia, arrhythmia and hyperlipidemia].
    Liu JX; Shang XH; Wang G
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Jul; 17(7):425-8. PubMed ID: 10322866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.